Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-028170
Filing Date
2019-11-26
Accepted
2019-11-26 17:36:57
Documents
1
Period of Report
2019-11-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8354
  Complete submission text file 0000899243-19-028170.txt   9749
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Issuer) CIK: 0001494650 (see all company filings)

EIN.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVISTA CAPITAL PARTNERS 65 EAST 55TH STREET, 18TH FLOOR NEW YORK NY 10022
Business Address
Venkataraman Sriram (Reporting) CIK: 0001550642 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38241 | Film No.: 191252341